Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Bile Duct Carcinoma”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Testing effectiveness (Phase 2)Looking for participantsNCT04982653
What this trial is testing

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Who this might be right for
Liver and Intrahepatic Bile Duct NeoplasmMetastatic Malignant Neoplasm in the LiverPrimary Malignant Liver Neoplasm
M.D. Anderson Cancer Center 140
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)UnknownNCT03943043
What this trial is testing

Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer

Who this might be right for
Cholangiocarcinoma
Istituto Clinico Humanitas 85
Testing effectiveness (Phase 2)Study completedNCT01153750
What this trial is testing

Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct

Who this might be right for
Advanced or Metastatic Cholangiocellular Carcinoma and Bile Duct
University Hospital Dresden 44
Testing effectiveness (Phase 2)Study completedNCT03639935
What this trial is testing

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT02053376
What this trial is testing

Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy

Who this might be right for
Metastatic Biliary Tract Carcinoma
Nathan Bahary, MD 43
Testing effectiveness (Phase 2)Study completedNCT00542048
What this trial is testing

A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Who this might be right for
Liver CancerNeoplasm Metastasis
MediGene 20
Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20
Not applicableNo Longer AvailableNCT04087876
What this trial is testing

Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations

Who this might be right for
Intrahepatic Cholangiocarcinoma
Basilea Pharmaceutica
Testing effectiveness (Phase 2)Looking for participantsNCT07831993
What this trial is testing

Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Study completedNCT00009893
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Alliance for Clinical Trials in Oncology 42
Testing effectiveness (Phase 2)UnknownNCT06430827
What this trial is testing

Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Ba Yi 20
Testing effectiveness (Phase 2)Looking for participantsNCT07450976
What this trial is testing

SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 151
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Study completedNCT02115542
What this trial is testing

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Who this might be right for
Cancer of the Bile Duct
H. Lee Moffitt Cancer Center and Research Institute 39
Testing effectiveness (Phase 2)Study completedNCT03260712
What this trial is testing

Pembrolizumab in Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerMetastatic CancerAdvanced Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 50
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT05346484
What this trial is testing

CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

Who this might be right for
Solid TumorSolid CarcinomaSolid Tumor, Adult+4 more
Imugene Limited 66
Next Page